Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

AMT October 28, 2025

American Tower Corporation Q3 2025 Earnings Call - Raised 2025 Guidance as CoreSite and Services Drive AFFO Upside

American Tower reported a strong Q3 2025, beating on key metrics and raising full-year guidance after a quarter of robust leasing, near-record services, and breakout data center performance at CoreSit...

  • Company raised full-year 2025 guidance across property revenue, adjusted EBITDA, attributable AFFO, and AFFO per share after a stronger-than-expected quarter.
  • Total revenue grew nearly 8% year over year; consolidated property revenue grew roughly 6% year over year.
  • Adjusted EBITDA grew about 8% year over year, with approximately 20 basis points of cash margin expansion since prior year.
  • +12 more takeaways
NEO October 28, 2025

NeoGenomics Q3 2025 Earnings Call - Record Clinical Growth and Radar ST MRD Cleared for Broad Clinical Launch

NeoGenomics delivered another quarter of record clinical volumes and double digit revenue growth, driven by strong NGS adoption, salesforce expansion in the community oncology channel, and the Pathlin...

  • Total revenue for Q3 2025 was $188 million, up 12% year over year, driven by record clinical volumes.
  • Clinical revenue grew strongly, up 15% on a same‑store basis excluding Pathline; total test volumes increased about 15% in Q3.
  • NGS revenue grew 24% year over year in the quarter, accounting for roughly one third of clinical revenue year to date, signaling meaningful share gains.
  • +13 more takeaways
ZBRA October 28, 2025

Zebra Technologies Q3 2025 Earnings Call - Beat Outlook; Elo and Tariff Mitigation Recenter Growth

Zebra beat its Q3 guide, delivering $1.3 billion in sales, margin improvement and double-digit EPS growth, while leaning on pricing, supply chain fixes and M&A to blunt tariff pain. Management framed ...

  • Q3 results topped guidance: sales $1.3 billion, up 5% year on year on a constant currency basis, adjusted EBITDA margin 21.6% (up 20 bps), non-GAAP EPS $3.88, up 11% y/y.
  • Company reported segment-level growth of Enterprise Visibility and Mobility (EVM) +2% and Asset Intelligence and Tracking (AIT) +11%, with historical results recast for two new forthcoming segments: Connected Frontline, and Asset Visibility and Automation.
  • Regional performance was mixed: Asia Pacific +23% (led by Australia, New Zealand, India and Japan), Latin America +8%, North America +6% (strength in mobile computing and RFID; Canada softer), EMEA down 3% with Germany and some manufacturing markets weak.
  • +12 more takeaways
ATI October 28, 2025

ATI Q3 2025 Earnings Call - Aerospace & Defense Surge to 70% of Revenue, Driving Margin Expansion and Raised Guidance

ATI closed Q3 2025 by beating estimates, accelerating its pivot into aerospace and defense, and raising full year targets. Revenue rose 7% year over year to above $1.1 billion, adjusted EPS was $0.85,...

  • Q3 revenue grew 7% year over year, topping $1.1 billion and beating expectations.
  • Adjusted EPS was $0.85, $0.10 above the high end of prior guidance.
  • Adjusted EBITDA totaled $225 million, which includes about $10 million from the sale of oil and gas rights; $215 million excluding that sale.
  • +13 more takeaways
LEG October 28, 2025

Leggett & Platt Third Quarter 2025 Earnings Call - Restructuring Near-Complete, Margins Up and Debt Cut While Demand Remains Soft

Leggett & Platt reported a quarter of disciplined execution. Sales were just over $1 billion, down 6% year over year, but restructuring and cost actions largely offset weak residential demand, driving...

  • Q3 sales just over $1.0 billion, down 6% year over year, driven by soft residential demand and sales attrition from the aerospace divestiture and restructuring.
  • GAAP EPS was $0.91, adjusted EPS was $0.29, down $0.03 year over year. Adjusted EBIT was $73 million, while reported EBIT was $171 million as stated on the call.
  • Management reaffirmed the midpoint of full-year guidance: sales $4.0 to $4.1 billion (down 6% to 9%), adjusted EPS $1.00 to $1.10, adjusted EBIT margin 6.4% to 6.6%, and cash from operations about $300 million.
  • +16 more takeaways
HRI October 28, 2025

Herc Holdings Inc. Third Quarter 2025 Earnings Call - Fast, Clean Integration Unlocks Visibility but Fleet Disposals Pressure Margins

Herc closed and integrated the H&E acquisition on a blistering timetable, finishing systems consolidation in 90 days and giving management, for the first time, unified, branch-level visibility heading...

  • Integration completed in 90 days, faster than the typical six to 18 months for similar transactions, delivering full systems visibility starting in Q4.
  • ERP and operations consolidation completed: H&E branch operations moved from SAP to Herc’s customized RentalMan front end and Oracle ERP framework.
  • ProControl by Herc Rentals has been rolled out to the combined customer base, enabling unified equipment renting, tracking, and asset management across the enlarged footprint.
  • +14 more takeaways
PHIN October 28, 2025

PHINIA Q3 2025 Earnings Call - SEM Acquisition Drives Record Sales and Cash Returns, Tariff Pass-Through Caps Margin Upside

PHINIA closed its first public-company acquisition, Swedish Electro Magnet Invest, in August, and reported a record quarter for adjusted sales and adjusted EBITDA while returning $41 million to shareh...

  • Closed acquisition of Swedish Electro Magnet Invest (SEM) in August, first acquisition as a public company, paid $47 million total, including $15 million cash to seller and $32 million to extinguish assumed debt.
  • Q3 net sales $908 million, up 8.2% year over year; excluding SEM and FX, organic revenue growth was about 5%.
  • Adjusted EBITDA was a record $133 million for PHINIA as a standalone company, with margin of 14.6%, a 30 basis point expansion year over year.
  • +15 more takeaways
MMYT October 28, 2025

MiqMatrip Limited Q2 FY26 Earnings Call - AI-powered Myra and international/non-air growth offset domestic air supply drag

MiqMatrip reported a quarter of operational momentum masked by accounting noise. Adjusted operating profit rose 18% year on year to $44.2m as international air and hotel revenue, bus ticketing and anc...

  • Adjusted operating profit climbed 18% YoY to $44.2m, showing underlying operating strength despite headline net loss.
  • Reported GAAP loss of $5.7m reflects ~ $28.3m of non-cash IFRS interest on zero‑coupon convertible notes plus a $14.3m foreign exchange translation loss, not cash operating weakness.
  • Domestic air revenues declined about 3% YoY, driven by short term supply constraints in the Indian aviation market, though MiqMatrip kept domestic market share above 30%.
  • +12 more takeaways
PYPL October 28, 2025

PayPal Q3 2025 Earnings Call - Pivot to diversified, profitable growth with dividend initiation

PayPal told investors the company has moved from stabilization to offense. Transaction margin dollars are growing again, driven by a broader mix across branded checkout, PSP, Venmo, and BNPL. Manageme...

  • PayPal reported transaction margin dollars excluding interest grew 7% in Q3, continuing a multi-quarter recovery from negative growth two years ago.
  • Management is on pace for 6% to 7% transaction margin dollar growth in 2025, and reiterated a longer-term target of high single-digit TM dollar growth and mid-teens non-GAAP EPS growth.
  • PayPal initiated a dividend, set as a 10% payout ratio to net income, while keeping buybacks as the primary capital return tool and targeting 70% to 80% of free cash flow for returns.
  • +14 more takeaways
KNSA October 28, 2025

Kiniksa Pharmaceuticals Third Quarter 2025 Earnings Call - ARCALYST acceleration lifts guidance to $670–675M as IL-1 franchise gains commercial traction

Kiniksa used this quarter to convert clinical validation into dollars. ARCALYST revenue jumped to $180.9 million in Q3, up 61% year over year, and management raised full-year net sales guidance to $67...

  • ARCALYST net sales in Q3 2025 were $180.9 million, up 61% year over year, driven by rising active patient counts and longer treatment duration.
  • Kiniksa raised full-year 2025 ARCALYST net sales guidance to $670 million to $675 million, up from $625 million to $640 million previously.
  • Management reports only about 15% penetration into the multiple recurrence (two or more flares) addressable population, signaling significant upside if adoption continues.
  • +13 more takeaways